{"id":528497,"date":"2010-04-15T10:39:58","date_gmt":"2010-04-15T14:39:58","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=73727"},"modified":"2010-04-15T10:39:58","modified_gmt":"2010-04-15T14:39:58","slug":"genocea-gets-2-7m-for-malaria-vaccine","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/528497","title":{"rendered":"Genocea Gets $2.7M for Malaria Vaccine"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/Biotech\/\">Biotech<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/vaccines\/\">vaccines<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/malaria\/\">Malaria<\/a><\/div>\n<p>\t\t<strong>Luke Timmerman wrote:<\/strong><\/p>\n<p>Genocea Biosciences, the Cambridge, MA-based developer of vaccines, <a href=\"http:\/\/www.businesswire.com\/portal\/site\/home\/permalink\/?ndmViewId=news_view&amp;newsId=20100415005179&amp;newsLang=en\">said today<\/a> it has been granted $2.7 million to work on discovering a new malaria vaccine. The grant is from the U.S. Army Medical Research and Materiel Command as part of a research collaboration with the Naval Medical Research Center. Genocea will use its technology to find target antigens for a vaccine, while the Naval Medical Research Center will contribute their expertise in developing sub-unit vaccine formulations.<\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/boston\/2010\/04\/15\/genocea-gets-2-7m-for-malaria-vaccine\/#comments\">Comments<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20Genocea%20Gets%20$2.7M%20for%20Malaria%20Vaccine%20http:\/\/xconomy.com\/?p=73727\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/boston\/2010\/04\/15\/genocea-gets-2-7m-for-malaria-vaccine\/&#038;t=Genocea%20Gets%20$2.7M%20for%20Malaria%20Vaccine\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/boston\/2010\/04\/15\/genocea-gets-2-7m-for-malaria-vaccine\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=Genocea+Gets+%242.7M+for+Malaria+Vaccine&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fboston%2F2010%2F04%2F15%2Fgenocea-gets-2-7m-for-malaria-vaccine%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>\n\t\t\t<a href='http:\/\/d1.openx.org\/ck.php?bannerid=' ><br \/>\n\t\t\t<img src='http:\/\/d1.openx.org\/avw.php?bannerid=&amp;cb=977' border='0' alt='' \/><\/a><br \/>\n\t\t\t<br \/>\n\t\t\t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=70c2596047c8cd43c8b033dc5012cf6b&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=70c2596047c8cd43c8b033dc5012cf6b&#038;p=1\"\/><\/a><br \/>\n<img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" style=\"display:none\" src=\"http:\/\/ib.adnxs.com\/seg?add=24595&#038;t=2\"\/><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/s6pschgLRfMVLRaUR_eCpfVKjhM\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/s6pschgLRfMVLRaUR_eCpfVKjhM\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/s6pschgLRfMVLRaUR_eCpfVKjhM\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/s6pschgLRfMVLRaUR_eCpfVKjhM\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/oiVSOimFWzA\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biotech, vaccines, Malaria Luke Timmerman wrote: Genocea Biosciences, the Cambridge, MA-based developer of vaccines, said today it has been granted $2.7 million to work on discovering a new malaria vaccine. The grant is from the U.S. Army Medical Research and Materiel Command as part of a research collaboration with the Naval Medical Research Center. Genocea [&hellip;]<\/p>\n","protected":false},"author":1192,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-528497","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/528497","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1192"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=528497"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/528497\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=528497"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=528497"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=528497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}